AAAAAA
Results:
1-14
|
Results: 14
Authors:
Santourlidis, S
Warskulat, U
Florl, AR
Maas, S
Pulte, T
Fischer, J
Muller, W
Schulz, WA
Citation: S. Santourlidis et al., Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappa B sites in prostatic carcinoma, MOL CARCINO, 32(1), 2001, pp. 36-43
Authors:
Steinhoff, C
Franke, KH
Golka, K
Thier, R
Romer, HC
Rotzel, C
Ackermann, R
Schulz, WA
Citation: C. Steinhoff et al., Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma, ARCH TOXIC, 74(9), 2000, pp. 521-526
Authors:
Steiner, M
Bastian, M
Schulz, WA
Pulte, T
Franke, KH
Rohring, A
Wolff, JM
Seiter, H
Schuff-Werner, P
Citation: M. Steiner et al., Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association, ARCH TOXIC, 74(4-5), 2000, pp. 222-225
Authors:
Kimura, F
Franke, KH
Steinhoff, C
Golka, K
Roemer, HC
Anastasiadis, AG
Schulz, WA
Citation: F. Kimura et al., Methyl group metabolism gene polymorphisms and susceptibility to prostaticcarcinoma, PROSTATE, 45(3), 2000, pp. 225-231
Authors:
Franke, KH
Miklosi, M
Goebell, P
Clasen, S
Steinhoff, C
Anastasiadis, AG
Gerharz, CD
Schulz, WA
Citation: Kh. Franke et al., Cyclin-dependent kinase inhibitor p27(KIP1) is expressed preferentially inearly stages of urothelial carcinoma, UROLOGY, 56(4), 2000, pp. 689-695
Authors:
Florl, AR
Franke, KH
Niederacher, D
Gerharz, CD
Seifert, HH
Schulz, WA
Citation: Ar. Florl et al., DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder, LAB INV, 80(10), 2000, pp. 1513-1522
Authors:
Meyer, AJ
Hernandez, A
Florl, AR
Enczmann, J
Gerharz, CD
Schulz, WA
Wernet, P
Ackermann, R
Citation: Aj. Meyer et al., Novel mutations of the von Hippel-Lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type, INT J CANC, 87(5), 2000, pp. 650-653
Authors:
Bruch, J
Schulz, WA
Haussler, J
Melzner, I
Bruderlein, S
Moller, P
Kemmerling, R
Vogel, W
Hameister, H
Citation: J. Bruch et al., Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines, CANCER RES, 60(16), 2000, pp. 4526-4530
Authors:
Oya, M
Schulz, WA
Citation: M. Oya et Wa. Schulz, Decreased expression of p57(KIP2) mRNA in human bladder cancer, BR J CANC, 83(5), 2000, pp. 626-631
Authors:
Lemm, I
Lingott, A
von Strandmann, EP
Zoidl, C
Bulman, MP
Hattersley, AT
Schulz, WA
Ebert, T
Ryffel, GU
Citation: I. Lemm et al., Loss of HNF1 alpha function in human renal cell carcinoma: Frequent mutations in the VHL gene but not the HNF1 alpha gene, MOL CARCINO, 24(4), 1999, pp. 305-314
Authors:
Santourlidis, S
Florl, A
Ackermann, R
Wirtz, HC
Schulz, WA
Citation: S. Santourlidis et al., High frequency of alterations in DNA methylation in adenocarcinoma of the prostate, PROSTATE, 39(3), 1999, pp. 166-174
Authors:
Anastasiadis, AG
Lemm, I
Radzewitz, A
Lingott, A
Ebert, T
Ackermann, R
Ryffel, GU
Schulz, WA
Citation: Ag. Anastasiadis et al., Loss of function of the tissue specific transcription factor HNF1 alpha inrenal cell carcinoma and clinical prognosis, ANTICANC R, 19(3A), 1999, pp. 2105-2110
Authors:
Christoph, F
Schmidt, B
Schmitz-Drager, BJ
Schulz, WA
Citation: F. Christoph et al., Over-expression and amplification of the c-myc gene in human urothelial carcinoma, INT J CANC, 84(2), 1999, pp. 169-173
Authors:
Florl, AR
Lower, R
Schmitz-Drager, BJ
Schulz, WA
Citation: Ar. Florl et al., DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas, BR J CANC, 80(9), 1999, pp. 1312-1321
Risultati:
1-14
|